Skip to main content

Specialty Pharmacy

  • NASP adds Walgreens, Pfizer and AstraZeneca execs to board

    WASHINGTON — The National Association of Specialty Pharmacy has added three new members to its board of directors. The organization brought on Walgreens VP federal government relations and U.S. public policy Ed Kaleta; Pfizer's regional president North America for rare disease Tolga Tangular; and AstraZeneca’s executive director of access services Blaine Squires. 
     

  • FDA approves Janssen’s plaque psoriasis drug Tremfya

    SILVER SPRING, Md. — The Food and Drug Adminisration has approved Janssen Biotech’s new treatment for plaque psoriasis, the company announced Thursday. Tremfya (guselkumab) is the first drug to be approved that selectively blocks a key plaque psoriasis cytokine, the company said.

  • PhRMA adds 2 VPs

    WASHINGTON — The Pharmaceutical Research and Manufacturers of America this week announced two new additions to its ranks. The company has added Mike Hotra as VP of its public affairs team, and Ken McKay as VP state government affairs. 
     

  • FDA grants full approval to Amgen’s Blincyto

    SILVER SPRING, Md. — Patients with a certain type of acute lymphoblastic leukemia have a new treatment option. The Food and Drug Administration has granted Amgen’s Blincyto (blinatumomab) full approval for the treatment of Philadelphia Chromosome-positive relaped or refractory B-cell precursor ALL.

  • Diplomat’s ThriveRx celebrates 10 years with new platforms

    CINCINNATI  — Diplomat Specialty Infusion Group’s nutrition division ThriveRx is celebrating 10 years of supporting parenteral and enteral nutrition patients with a website redesign and the rebrand of its Maximize Health program. The redesigned thriverx.diplomat.is features a new look with improved organization in an effort to improve the patient and health care professional experience on the site.

  • Walmart gets specialty pharmacy accreditation from URAC

    BENTONVILLE, Ark. — Walmart on Thursday announced that it had received specialty pharmacy accreditation from URAC. The distinction means the company has met the accreditor’s standards for demonstrated quality care, improved processes and positive patient outcomes, Walmart said. 
     

  • FDA approves new indication for Amgen’s Vectibix

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new indication for Amgen’s Vectibix (panitumumab). The biologic has been approved to treat patients with wild-type RAS metastatic colorectal cancer, the company announced Thursday.

  • Natco Pharma gets FDA approval for generic Vidaza

    SILVER SPRING, Md. — The Food and Drug Administration has approved Natco Pharma’s generic of Celgene and Breckenridge’s Vidaza (azacitidine for injection). The drug is indicated to treat myelodysplastic syndrome.
     
    Natco’s generic will be available in a dosage strength of 100 mg per vial. The drug had combined sales of $188 million for the 12 months ended April 2017, the company said.
     
X
This ad will auto-close in 10 seconds